Vice President, Investor Relations - Vancouver, Canada - Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc.
Verified Company
Vancouver, Canada

2 weeks ago

Sophia Lee

Posted by:

Sophia Lee

beBee Recruiter


Description

Who We Are:
At Xenon Pharmaceuticals (


NASDAQ:
XENE), we are committed to providing a brighter future for patients suffering from neurological disorders.

Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver innovative medicines for patients in need.

We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.


What We Do:
We are advancing an exciting pipeline of neurology-focused therapies, with a focus on commercializing novel treatments for epilepsy.

Building upon the positive results and compelling data from our XEN1101 Phase 2b "X-TOLE" study in adult patients with focal epilepsy, our XEN1101 Phase 3 program includes studies in adult patients with focal onset seizures and primary generalized tonic clonic seizures.

In addition, XEN1101 is being evaluated as a treatment for major depressive disorder in both a company-sponsored Phase 2 clinical trial, as well as an investigator-led proof-of-concept study.

Xenon's proprietary, pediatric formulation of ezogabine, XEN496, is being studied in a Phase 3 clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy.

We are also proud of the leading-edge science coming out of our discovery labs, where many innovative, early-stage research programs are underway.

In addition to these proprietary programs, our pipeline includes clinical-stage partnered programs with valued collaborators.

Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.


About the Role:

RESPONSIBILITIES:

  • Provide IR strategic counsel and develop key messages for use with investors and analysts.
  • Develop annual and longer term strategic investor relations plans to communicate the company's strategies and progress to the investment community.
  • Lead and manage the company's participation in banking conferences, nondeal roadshows, and analyst/investor days.
  • Partner with corporate affairs and legal teams to ensure all external communications are accurate and consistent with corporate messaging including presentation decks, news releases, quarterly earnings and other conference call scripts, management Q&As, content for investor tab of the corporate website, and the business sections of quarterly and annual SEC filings.
  • Lead development of briefing materials for management in preparation for investor meetings.
  • Along with CEO, CFO, and other members of the Senior Executive Team, serve as spokesperson for the company at investment presentations, individual investor meetings and discussions as needed.
  • Serve as primary point of contact for investment community: cultivate and maintain strong relationships with investors (current and potential future), sellside research analysts, and other key stakeholders; provide timely, consistent, compliant, and accurate responses; maintain database of interactions; and convey sentiments and feedback to management.
  • Track and analyze shareholder base and investment trends for the company, its peers, and its competitors to inform investor targeting strategy and monitor impact of strategy over time.
  • Work closely with CEO, CFO to establish the optimal mix of shareholders through targeting initiatives.
  • Track and analyze sellside models, including comparison to internal forecasts, to assess expectations and determine implications for analyst and investor communications.
  • Work with Competitive Intelligence function and other leaders across the company to monitor competitors' performance along with industry, regulatory, and other relevant trends to inform differentiated corporate messaging.
  • Support the development and execution of the company's financing strategy.
  • Collaborate on execution of the annual meeting of shareholders together with the Legal, Finance, and Corporate Affairs teams.
  • Develop and propose short
- and long-term goals for the Investor Relations function in accordance with overall Company strategies.

  • Plan and manage budget proposals and approved budgets in accordance with the Company's strategic and operating plans and Finance.
  • Recruit, lead, direct, develop, coach and evaluate direct reports, if any, in accordance with the Company's Human Resource policies and practices.
  • Act in accordance with Company policies, including, for example, the Code of Business Conduct and Ethics and ensure policies are understood and followed by direct reports, if any.
  • Travel will be required.
  • Other duties as assigned.

QUALIFICATIONS:

  • MBA, M.D., or relevant Ph.
D. required.

  • Minimum 10 years of experience on the buyside or sellside in biotech/pharmaceuticals; neurology experience, specifically epilepsy, highly desirable.
  • Proven track record of developing positive longterm relations

More jobs from Xenon Pharmaceuticals Inc.